I think if you read the Smith retort to the SA posting you will understand why Cognate is a good deal.
Your USA comment really makes no sense. The EU wants manufacturing capability with the vaccine. And Cognate does work providing technology transfer and training on top of the development and manufacturing here in the good ol' USA.
If I mistrusted management as you seem to, I never would invest. You only seem to confirm today's nonsense SA article. Linda must be selling the vaccine in Israeli alleyways and pocketing the proceeds.